Dr. Churpek on Gene Mutations in Breast Cancer

Jane E. Churpek, MD
Published Online: Thursday, June 6, 2013
Jane E. Churpek, MD, medical oncologist, hematologist, The University of Chicago, discusses a study that found the inherited mutations in breast cancer genes in African American breast cancer patients were revealed by targeted genomic capture and next-generation sequencing.

It is known, Churpek says, that ATM and CHEK2 are considered moderate penetrants breast cancer susceptibility genes and increase the lifetime risk of disease by two- to threefold. PTEN also has known risks for breast cancer, colon cancer, endometrial cancer, and thyroid cancer.

The panel on the study also found a woman with two bad copies of a CHEK2 mutation, which further increased her risk. In broad screenings, Churpek says that these unique situations can be identified and give more meaning to what is already known about specific gene mutations.

<<< View more from the 2013 ASCO Annual Meeting

Online CME Activities
Free CME from PER
Oncology Briefing: Advances in Estrogen Receptor-Positive Breast Cancer
OncoLogue: Cases in Chronic Myeloid Leukemia, Myelofibrosis, Myelodysplastic Syndromes, and Acute Myeloid Leukemia
Coping With Confidence: Online Clinical Case Discussions
OncoLogue: Cases in Follicular Lymphoma, Chronic Lymphocytic Leukemia, and Multiple Myeloma
More Reading
Publications
$auto_registration$